Manufacturing

Sep 20, 2018
By BioPharm International Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
Sep 20, 2018
By BioPharm International Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
Sep 17, 2018
By BioPharm International Editors
The provider of plant-based ingredients will present recently launched multi-compendial materials for upstream and downstream biopharmaceutical applications.
Sep 14, 2018
By BioPharm International Editors
Avara Pharmaceutical Services acquired Sandoz’s sterile manufacturing facility for injectable medicines in Boucherville, Quebec, Canada.
Sep 13, 2018
By BioPharm International Editors
The collaboration will focus on developing manufacturing solutions for biosimilars.
Sep 13, 2018
By BioPharm International Editors
The new features on the purifier deliver additional sizes and sterilization/sanitization compatibility.
Sep 07, 2018
By BioPharm International Editors
ICS distribution center will serve manufacturers of specialty medications, biosimilars, and cell and gene therapies.
Sep 07, 2018
By BioPharm International Editors
Bio-Rad introduces CHT Ceramic Hydroxyapatite XT media and Nuvia HP-Q resin resin for process protein purification.
Sep 06, 2018
By BioPharm International Editors
The company is increasing manufacturing capacity at its Copenhagen, Denmark facility with the addition of six new bioreactors.
Sep 04, 2018
By BioPharm International Editors
A collaboration integrates Sartorius Stedim Biotech’s BIOSTAT STR bioreactors and Repligen’s XCell ATF cell-retention control technology to create simplified, scalable equipment for intensified cell culture.
native1_300x100
lorem ipsum